Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria

Modern Pathology

Volumn 22, Issue 8, 2009, Pages 985-988

  Semmel, Dana R ^a   Folkins, Ann K ^a   Hirsch, Michelle S ^a   Nucci, Marisa R ^a   Crum, Christopher P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

BRCA; Fallopian tube; Ovarian carcinoma; Serous carcinoma

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; KI 67 ANTIGEN; PROTEIN P53;

AGED; ARTICLE; BLOATING; CANCER INVASION; CANCER RISK; CASE REPORT; CONSTIPATION; DIARRHEA; EARLY DIAGNOSIS; FEMALE; FIBROMA; FIMBRIA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; PRIORITY JOURNAL; SALPINGECTOMY; SALPINGOOOPHORECTOMY; UTERINE TUBE; UTERINE TUBE CARCINOMA;

AGED; CYSTADENOCARCINOMA, SEROUS; FALLOPIAN TUBE NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENTAL FINDINGS; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS; PELVIC NEOPLASMS; SPECIMEN HANDLING;

EID: 68249131683     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.64     Document Type: Article

References (14)

1. Cass I, Holschneider C, Datta N, et al. BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype? Obstet Gynecol 2005;106:1327-1334.
2. Culton LK, Deavers MT, Silva EG, et al. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases. Am J Surg Pathol 2006;30:844-849.
3. Bossuyt V, Medeiros F, Drapkin R, et al. Adenofibroma of the fimbria: a common entity that is indistinguishable from ovarian adenofibroma. Int J Gynecol Pathol 2008;27:390-397.
4. Finch A, Shaw P, Rosen B, et al. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol 2006;100:58-64.
5. Callahan MJ, Crum CP, Medeiros F, et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 2007;25:3985-3990.
6. Kindelberger DW, Lee Y, Miron A, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 2007;31:161-169.
7. Carlson JW, Miron A, Jarboe EA, et al. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol 2008;26: 4160-4165.
8. Medeiros F, Muto MG, Lee Y, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 2006;30:230-236.
9. Robboy SJ, Mutter GL, Shako-Levy R, et al. Cutup-gross description and processing of specimens, Chapter 35, In: Robboy SJ, Mutter GL, Prat J, Bentley RC, Russell P, Anderson MC (eds). Robboy's Pathology of the Female Reproductive Tract, 2nd edn. Churchille Livingstone: Oxford, 2009, pp 989-991.
10. Longacre TA, Oliva E, Soslow RA, Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of fallopian tube neoplasms. Hum Pathol 2007;38:1160-1163.
11. Nossov V, Amneus M, Su F, et al. The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125? Am J Obstet Gynecol 2008;199:215-223.
12. Maehle L, Apold J, Paulsen T, et al. High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers. Clin Cancer Res 2008;14:7569-7573.
13. Olopade OI, Artioli G. Efficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations. Breast J 2004;10(Suppl 1): S5-S9.
14. Modugno F, Ness RB, Allen GO, et al. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am J Obstet Gynecol 2004;191: 733-740.